“unity-biotechnology” Archives

in
Entry Author Date Location
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More 09/18/20 National
Unity Bio Restructuring Cuts 30% of Staff, Keeps Focus on Eye Drug 09/15/20 San Francisco
Bio Roundup: Pharma M&A, AbbVie’s Cancer Bet, Biofourmis Bucks & More 09/04/20 National
Bio Roundup: J&J Buyout, BioMarin Rebuffed, Poseida on Hold & More 08/21/20 National
Unity Biotech Arthritis Drug Flunks Phase 2, Spelling Program’s End 08/18/20 San Francisco
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More 03/06/20 National
Bio Roundup: Array Bio Acquired, IPO Spree, Sanofi’s Job Cuts & More 06/21/19 National
Bio Roundup: IDO Fallout, Express Scripts Dumps Amgen, Isaly Out & More 05/04/18 National
Unity Biotech IPO Raises $85M to Test Drugs for Diseases of Aging 05/02/18 San Francisco
Bio Roundup: Lung Cancer Showdown, Gene Therapy Deals, IPO Busts 04/13/18 National
Unity Biotech Files IPO to Bring Anti-Aging Drugs into Clinical Trials 04/06/18 San Francisco
Anti-Aging Startup Unity Bio Grabs $55M, Plans First Clinical Trial 03/19/18 San Francisco
Texas Roundup: SXSW Odds & Ends, Dosh, Mythic, Peloton, & More 03/22/17 Texas
UNITY Biotechnology Lands $116,000,000 Series B Funding 10/31/16 San Francisco
Bio Roundup: Drug Pricing, Cystic Fibrosis Showdown, Myovant & More 10/28/16 National
Unity Nabs $116M To Bring “Diseases of Aging” Drugs Into Human Trials 10/27/16 San Francisco
Biotech’s Recent Headlines, Reimagined In Verse and On Stage 02/16/16 National
West Coast Bio Roundup: Tessier-Lavigne, Twist, Unity, Grail & More 02/05/16 San Francisco
Unity Biotechnology Receives New Financing 02/04/16 San Francisco
Unity Bio Wants To “Lengthen Health Span,” But 1st Goals More Modest 02/03/16 San Francisco
Page 1 of 1